Clinical trial
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
NCT00006131 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
- Lead sponsor
- National Center for Research Resources (NCRR)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 1997
- Completion date
- Not reported
- Enrollment
- 66 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.